tert-Butyl 4-(5-amino-3-methyl-1H-pyrazol-1-yl)piperidine-1-carboxylate

Catalog No. :
ACZDJS854
CAS No. :
1177348-32-1
Molecular Formula :
C14H24N4O2
Molecular Weight :
280.37

IUPAC Name:tert-butyl 4-(5-amino-3-methyl-1H-pyrazol-1-yl)piperidine-1-carboxylate

tert-Butyl 4-(5-amino-3-methyl-1H-pyrazol-1-yl)piperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$156.00Login to see priceInquiryInquiry
250mg95%$252.00Login to see priceInquiryInquiry
1g95%$601.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-(5-amino-3-methyl-1H-pyrazol-1-yl)piperidine-1-carboxylate
IUPAC Nametert-butyl 4-(5-amino-3-methyl-1H-pyrazol-1-yl)piperidine-1-carboxylate
MDL No.MFCD08457384
Molecular FormulaC14H24N4O2
Molecular Weight280.37
SMILESO=C(N1CCC(N2N=C(C)C=C2N)CC1)OC(C)(C)C
InChI KeyAJRMCPFXYIZYGY-UHFFFAOYSA-N
Synonym1-piperidinecarboxylic acid, 4-(5-amino-3-methyl-1H-pyrazo;tert-butyl 4-(5-amino-3-methyl-1H-pyrazol-1-yl)piperidine-1-carboxylate;1-Piperidinecarboxylic acid, 4-(5-amino-3-methyl-1H-pyrazol-1-yl)-, 1,1-dimethylethyl ester
CAS No.1177348-32-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACZDJS854 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZDJS854 route product structure diagram
    ACZDJS8541177348-32-1
Inquiry

2. ACZDJS854 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZDJS854 route product structure diagram
    ACZDJS8541177348-32-1
Inquiry

Comments (0)